Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Neoplasms of the CNS

  Free Subscription


18.05.2020

1 Acta Neuropathol
1 Arch Pathol Lab Med
1 BMC Cancer
1 BMC Neurol
1 Br J Cancer
1 Br J Neurosurg
2 Childs Nerv Syst
6 J Neurooncol
2 J Neurosurg
6 Neuro Oncol
1 Neuroradiology
1 Neurosurgery
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. WILLIAMS EA, Wakimoto H, Shankar GM, Barker FG 2nd, et al
    Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features.
    Acta Neuropathol. 2020 May 13. pii: 10.1007/s00401-020-02161.
    PubMed        


    Arch Pathol Lab Med

  2. LOUIS DN, Wesseling P, Brandner S, Brat DJ, et al
    Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer Reporting.
    Arch Pathol Lab Med. 2020;144:196-206.
    PubMed         Abstract available


    BMC Cancer

  3. KIESEL B, Thome CM, Weiss T, Jakola AS, et al
    Perioperative imaging in patients treated with resection of brain metastases: a survey by the European Association of Neuro-Oncology (EANO) Youngsters committee.
    BMC Cancer. 2020;20:410.
    PubMed         Abstract available


    BMC Neurol

  4. HSU BH, Lee WH, Yang ST, Han CT, et al
    Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
    BMC Neurol. 2020;20:178.
    PubMed         Abstract available


    Br J Cancer

  5. SIELSKA M, Przanowski P, Pasierbinska M, Wojnicki K, et al
    Tumour-derived CSF2/granulocyte macrophage colony stimulating factor controls myeloid cell accumulation and progression of gliomas.
    Br J Cancer. 2020 May 11. pii: 10.1038/s41416-020-0862.
    PubMed         Abstract available


    Br J Neurosurg

  6. BANAAMA S, Temel Y
    A case report of an intra-optic recurrent craniopharyngioma.
    Br J Neurosurg. 2020 May 12:1-3. doi: 10.1080/02688697.2020.1760207.
    PubMed         Abstract available


    Childs Nerv Syst

  7. MORRALL MCHJ, Reed-Berendt R, Moss K, Stocks H, et al
    Neurocognitive, academic and functional outcomes in survivors of infant ependymoma (UKCCSG CNS 9204).
    Childs Nerv Syst. 2018 Dec 15. pii: 10.1007/s00381-018-4015.
    PubMed         Abstract available

  8. TSUCHIMOCHI K, Morioka T, Murakami N, Yamashita F, et al
    Huge multiple spinal extradural meningeal cysts in infancy.
    Childs Nerv Syst. 2018 Nov 23. pii: 10.1007/s00381-018-4009.
    PubMed         Abstract available


    J Neurooncol

  9. LU VM, O'Connor KP, Shah AH, Eichberg DG, et al
    The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature.
    J Neurooncol. 2020 May 8. pii: 10.1007/s11060-020-03528.
    PubMed         Abstract available

  10. DI L, Heath RN, Shah AH, Sanjurjo AD, et al
    Resection versus biopsy in the treatment of multifocal glioblastoma: a weighted survival analysis.
    J Neurooncol. 2020 May 11. pii: 10.1007/s11060-020-03508.
    PubMed         Abstract available

  11. DE BLANK P, Fouladi M, Huse JT
    Molecular markers and targeted therapy in pediatric low-grade glioma.
    J Neurooncol. 2020 May 12. pii: 10.1007/s11060-020-03529.
    PubMed         Abstract available

  12. WEE CW, Kim IH, Park CK, Kim N, et al
    Correction to: Chemoradiation in elderly patients with glioblastoma from the multiinstitutional GBMmolRPA cohort: is shortcourse radiotherapy enough or is it a matter of selection?
    J Neurooncol. 2020 May 12. pii: 10.1007/s11060-020-03532.
    PubMed         Abstract available

  13. HOFMANN S, Schmidt MA, Weissmann T, Eyupoglu I, et al
    Evidence for improved survival with bevacizumab treatment in recurrent high-grade gliomas: a retrospective study with ("pseudo-randomized") treatment allocation by the health insurance provider.
    J Neurooncol. 2020 May 14. pii: 10.1007/s11060-020-03533.
    PubMed         Abstract available

  14. NI XR, Zhao YY, Cai HP, Yu ZH, et al
    Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models.
    J Neurooncol. 2020 May 13. pii: 10.1007/s11060-020-03527.
    PubMed         Abstract available


    J Neurosurg

  15. FATIMA N, Ding VY, Han SS, Chang SD, et al
    Predictors of visual functional outcome following treatment for cavernous sinus meningioma.
    J Neurosurg. 2020 May 15:1-12. doi: 10.3171/2020.2.JNS193009.
    PubMed         Abstract available

  16. JULIE DA, Lazow SP, Vanderbilt DB, Taube S, et al
    A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
    J Neurosurg. 2020 May 15:1-8. doi: 10.3171/2020.3.JNS193419.
    PubMed         Abstract available


    Neuro Oncol

  17. SCHELL M, Pfluger I, Brugnara G, Isensee F, et al
    Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
    Neuro Oncol. 2020 May 11. pii: 5836012. doi: 10.1093.
    PubMed         Abstract available

  18. ECKEL-PASSOW JE, Drucker KL, Kollmeyer TM, Kosel ML, et al
    Adult Diffuse Glioma GWAS by Molecular Subtype Identifies Variants in D2HGDH and FAM20C.
    Neuro Oncol. 2020 May 9. pii: 5835318. doi: 10.1093.
    PubMed         Abstract available

  19. BARONI LV, Sampor C, Gonzalez A, Lubieniecki F, et al
    Bridging the treatment gap in infant medulloblastoma: Molecularly informed outcomes of a globally feasible regimen.
    Neuro Oncol. 2020 May 15. pii: 5837622. doi: 10.1093.
    PubMed         Abstract available

  20. DI STEFANO AL, Picca A, Saragoussi E, Bielle F, et al
    Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusions.
    Neuro Oncol. 2020 May 15. pii: 5837595. doi: 10.1093.
    PubMed         Abstract available

  21. GRIL B, Wei D, Zimmer AS, Robinson C, et al
    A HER2 Antibody Drug Conjugate Controls Growth of Breast Cancer Brain Metastases in Hematogenous Xenograft Models, with Heterogeneous Blood-Tumor Barrier Penetration Unlinked to a Passive Marker.
    Neuro Oncol. 2020 May 9. pii: 5835334. doi: 10.1093.
    PubMed         Abstract available

  22. GOLDMAN S, Pollack IF, Jakacki RI, Billups CA, et al
    Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
    Neuro Oncol. 2020 May 11. pii: 5836011. doi: 10.1093.
    PubMed         Abstract available


    Neuroradiology

  23. KOGUE R, Maeda M, Umino M, Tsuchiya K, et al
    Evaluation of a high-signal lesion posterior to the intracranial vertebral artery using 3D balanced fast-field echo imaging.
    Neuroradiology. 2019 Aug 6. pii: 10.1007/s00234-019-02270.
    PubMed         Abstract available


    Neurosurgery

  24. IVO D'URSO P
    Letter: An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning.
    Neurosurgery. 2020 May 15. pii: 5837546. doi: 10.1093.
    PubMed        


    PLoS One

  25. SHIEH LT, Guo HR, Ho CH, Lin LC, et al
    Survival of glioblastoma treated with a moderately escalated radiation dose-Results of a retrospective analysis.
    PLoS One. 2020;15:e0233188.
    PubMed         Abstract available

  26. SUAREZ-GARCIA JG, Hernandez-Lopez JM, Moreno-Barbosa E, de Celis-Alonso B, et al
    A simple model for glioma grading based on texture analysis applied to conventional brain MRI.
    PLoS One. 2020;15:e0228972.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  27. RAJESH Y, Biswas A, Kumar U, Banerjee I, et al
    Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.
    Proc Natl Acad Sci U S A. 2020 May 14. pii: 1921531117.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: